Advanced Filters
noise
Found 1,274 clinical trials
M Muriel Vicent-Gil, Dr

Study the Efficacy and Safety of the INtegral Cognitive REMediation Program (INCREM) for Depression

Feeling sad about negative or stressful events has nothing to do with the diagnosis of depression, as this is a very prevalent mental illness among the population with devastating consequences for the person suffering from it. Symptoms range from mood swings, extreme sadness, apathy, inability to feel pleasure, to sleep …

18 years of age All Phase 3
P Pandora Lam

Sleep Mechanisms Of Regulating Emotions

This project is the second phase of a two-phased project investigating the impact of a proven sleep intervention, Cognitive Behavioral Therapy for Insomnia (CBT-I) on engagement of the emotion regulation brain network as a putative mechanistic target.

25 - 60 years of age All Phase N/A
L Lisle Allen, BS

Neural and Psychiatric Consequences of Cannabis Use in Adolescents

The goal of this study is to investigate the effects of cannabis on brain function among adolescents with depression.

14 - 20 years of age All Phase N/A
M Mohana Priya Santhan Ramesh Kumar Padma, Masters

Improving Outcomes in Adolescent Inpatient Depression With Deep Transcranial Magnetic Stimulation

Evaluate the feasibility, safety, and preliminary efficacy of deep Transcranial Magnetic Stimulation (dTMS) as an adjunctive treatment for adolescents hospitalized with major depressive disorder (MDD).

14 - 18 years of age All Phase N/A
A Afifa Humaira

Patient-oriented Randomized Pragmatic Feasibility Trial with RTMS in Depression and Anxiety

This trial compares intermittent theta-burst stimulation (iTBS) to low frequency repetitive transcranial magnetic stimulation (LFR) in regards to depression and anxiety outcomes in 100 patients with treatment resistant depression (TRD).

18 years of age All Phase N/A

pBFS Guided rTMS Over DMPFC for Treatment-Resistant Depression

Investigators aim to evaluate the safety and efficacy of pBFS-guided rTMS therapy targeting DMPFC for patients with treatment-resistant depression

18 - 65 years of age All Phase N/A
I Isha Trivedi

DBS for TRD With the Medtronic Percept PC

Of the estimated 30 million Americans who suffer from Major Depressive Disorder, approximately 10% are considered treatment resistant. Deep brain stimulation (DBS) to a region of the brain called the subcallosal cingulate (SCC) is an emerging strategy for treatment resistant depression (TRD), which involves placement of electrodes in a specific …

25 - 70 years of age All Phase N/A
C Chih-Ming Cheng, M.D.

Dorsomedial Prefrontal Neuromodulation in Treatment-resistant Depression

Major depressive disorder (MDD) is a common and troublesome disorder, with high risk of physical and psychiatric comorbidity. At least one-third of patients could not achieve a response after several antidepressant trials, so-called treatment-refractory depression (TRD). The high-frequency repetitive transcranial magnetic stimulation (rTMS) or intermittent theta-burst stimulation (iTBS) at left-sided …

21 - 70 years of age All Phase N/A
R Renrong Wu, PhD, M.D

aiTBS for Relieving NSSI in Depressive Patients

Repetitive transcranial magnetic stimulation (rTMS) has been successfully used to help patients with treatment resistant depression. However, its role in alleviating self injuries without suicidal ideation remained uncertain. This trial will compare the effectiveness of active accelerated intermittent theta burst stimulation (aiTBS) rTMS to a placebo control on non-suicidal self …

12 - 18 years of age All Phase N/A
C Conor Liston, MD, PhD

Biomarker-guided rTMS for Treatment Resistant Depression

Repetitive transcranial magnetic stimulation (rTMS) is a treatment for depression. The investigators are continuing to learn how to optimize outcomes from rTMS treatment. The purpose of this research project is to use brain network connectivity patterns as measured by resting state functional magnetic resonance imaging (fMRI) to confirm a way …

22 - 65 years of age All Phase 3

Simplify language using AI